Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
GLP-1s: A Master Regulator with Anti-Inflammatory Powers GLP-1 is a natural hormone secreted by your gut after eating, primarily known for stimulating insulin release, suppressing glucagon, and reducing appetite
Some common side effects include: Nausea : this usually goes away over time Diarrhoea: this usually goes away over time Low blood sugar (hypoglycaemia): This is more likely to happen in people with diabetes that are already taking other diabetes medications
Microdosing uses smaller, individualized doses tailored to your goals and tolerance
This dual mechanism produces stronger appetite suppression and greater metabolic effects in clinical trials
Novo Nordisk's head of US operations, James Millar, said the list price reductions are "the best approach to address the unprecedented opportunity to help more than 100 million people living with obesity and over 35 million people with type 2 diabetes in the US." He went on to say that "private and public payers, as well as patients, want access and have been calling for lower list prices." It is estimated that around one in eight people in the US were taking incretin medicines for weight loss in 2025, according to KFF Health
US$ 29.57
US$ 22.97
US$ 24.15
US$ 22.90
